PHARMACOTHERAPY (BCPS) EXAM|
COMPREHENSIVE EXAM WITH CORRECT
VERIFIED ANSWERS
First-line therapy for type 2 diabetes mellitus in adults
without contraindications:
A. Metformin
B. Glyburide
C. Insulin
D. Pioglitazone
✅ Answer: A. Metformin
Rationale: Preferred initial therapy due to efficacy, safety,
weight neutrality, and cardiovascular benefit.
2. The target LDL for a patient with ASCVD per 2023
guidelines:
A. <100 mg/dL
B. <70 mg/dL
C. <130 mg/dL
D. <55 mg/dL
✅ Answer: B. <70 mg/dL
,Rationale: High-risk ASCVD patients have LDL goal <70
mg/dL.
3. First-line therapy for acute exacerbation of heart failure
with volume overload:
A. Furosemide
B. Spironolactone
C. Metoprolol
D. Lisinopril
✅ Answer: A. Furosemide
Rationale: Loop diuretics rapidly reduce fluid overload.
4. Which antihypertensive is preferred in chronic kidney
disease with proteinuria?
A. ACE inhibitor
B. Thiazide diuretic
C. Calcium channel blocker
D. Beta-blocker
✅ Answer: A. ACE inhibitor
Rationale: Slows progression of CKD and reduces
proteinuria.
,5. First-line treatment for H. pylori infection:
A. Triple therapy (PPI + clarithromycin +
amoxicillin/metronidazole)
B. PPI alone
C. Antacids only
D. Bismuth only
✅ Answer: A. Triple therapy
Rationale: Eradication therapy combines PPI and
antibiotics.
6. Statin therapy for a 45-year-old with LDL 160 mg/dL and
no other risk factors:
A. Moderate-intensity statin
B. High-intensity statin
C. Ezetimibe monotherapy
D. Lifestyle modification only
✅ Answer: A. Moderate-intensity statin
Rationale: Based on risk profile and primary prevention
guidelines.
7. Preferred anticoagulant for non-valvular atrial fibrillation
in a patient with normal renal function:
, A. Apixaban
B. Warfarin
C. Dabigatran
D. Rivaroxaban
✅ Answer: A. Apixaban
Rationale: Direct oral anticoagulants preferred for efficacy,
safety, and convenience.
8. The primary therapy for acute gout flare:
A. Colchicine
B. Allopurinol
C. Febuxostat
D. Probenecid
✅ Answer: A. Colchicine
Rationale: Treats acute inflammation; urate-lowering
therapy started after flare resolution.
9. First-line therapy for chronic heart failure with reduced
ejection fraction (HFrEF):
A. ACE inhibitor + beta-blocker + diuretic
B. Digoxin only
C. Loop diuretic only
COMPREHENSIVE EXAM WITH CORRECT
VERIFIED ANSWERS
First-line therapy for type 2 diabetes mellitus in adults
without contraindications:
A. Metformin
B. Glyburide
C. Insulin
D. Pioglitazone
✅ Answer: A. Metformin
Rationale: Preferred initial therapy due to efficacy, safety,
weight neutrality, and cardiovascular benefit.
2. The target LDL for a patient with ASCVD per 2023
guidelines:
A. <100 mg/dL
B. <70 mg/dL
C. <130 mg/dL
D. <55 mg/dL
✅ Answer: B. <70 mg/dL
,Rationale: High-risk ASCVD patients have LDL goal <70
mg/dL.
3. First-line therapy for acute exacerbation of heart failure
with volume overload:
A. Furosemide
B. Spironolactone
C. Metoprolol
D. Lisinopril
✅ Answer: A. Furosemide
Rationale: Loop diuretics rapidly reduce fluid overload.
4. Which antihypertensive is preferred in chronic kidney
disease with proteinuria?
A. ACE inhibitor
B. Thiazide diuretic
C. Calcium channel blocker
D. Beta-blocker
✅ Answer: A. ACE inhibitor
Rationale: Slows progression of CKD and reduces
proteinuria.
,5. First-line treatment for H. pylori infection:
A. Triple therapy (PPI + clarithromycin +
amoxicillin/metronidazole)
B. PPI alone
C. Antacids only
D. Bismuth only
✅ Answer: A. Triple therapy
Rationale: Eradication therapy combines PPI and
antibiotics.
6. Statin therapy for a 45-year-old with LDL 160 mg/dL and
no other risk factors:
A. Moderate-intensity statin
B. High-intensity statin
C. Ezetimibe monotherapy
D. Lifestyle modification only
✅ Answer: A. Moderate-intensity statin
Rationale: Based on risk profile and primary prevention
guidelines.
7. Preferred anticoagulant for non-valvular atrial fibrillation
in a patient with normal renal function:
, A. Apixaban
B. Warfarin
C. Dabigatran
D. Rivaroxaban
✅ Answer: A. Apixaban
Rationale: Direct oral anticoagulants preferred for efficacy,
safety, and convenience.
8. The primary therapy for acute gout flare:
A. Colchicine
B. Allopurinol
C. Febuxostat
D. Probenecid
✅ Answer: A. Colchicine
Rationale: Treats acute inflammation; urate-lowering
therapy started after flare resolution.
9. First-line therapy for chronic heart failure with reduced
ejection fraction (HFrEF):
A. ACE inhibitor + beta-blocker + diuretic
B. Digoxin only
C. Loop diuretic only
